Dr. Maixner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
UH-South, F6232
Ann Arbor, MI 48109Phone+1 734-936-9760
Summary
- Dr. Daniel Maixner is a psychiatrist in Ann Arbor, MI and is affiliated with Michigan Medicine. He received his medical degree from University of Nebraska College of Medicine and has been in practice 25 years. He is experienced in electroconvulsive therapy, catatonia, transcranial magnetic stimulation, treatment resistant depression, and vagus nerve stimulation.
Education & Training
- University of MichiganMS, Clinical Research Design and Statistical Analysis, 2007 - 2009
- University of MichiganResidency, Psychiatry, 1992 - 1996
- University of Nebraska College of MedicineClass of 1992
Certifications & Licensure
- MI State Medical License 1994 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 1 citationsCognitive effects of electroconvulsive therapy in depressed adolescents.Neera Ghaziuddin, Shawn M McClintock, Daniel F Maixner, Leslie R Miller, Mustafa Husain
Journal of Affective Disorders. 2024-07-01 - 2 citationsClinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression.Sagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, Eric Achtyes, Fernando S Goes
Journal of Affective Disorders. 2024-03-01 - 3 citationsNational Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy.Peter P Zandi, Michael Morreale, Irving M Reti, Daniel F Maixner, William M McDonald
The Journal of ECT. 2022-09-01
Journal Articles
- Cost-Effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United StatesEric L Ross, Daniel F Maixner, JAMA
Press Mentions
- Ketamine Shows Promise for Hard-to-Treat Depression in New StudyMay 26th, 2023
- Pandemic Shows Essential Role of ECT as Treatment for Severe DepressionJune 2nd, 2021
- Pandemics Show an Important Role for ECT as a Treatment for Severe DepressionJune 2nd, 2021
- Join now to see all
Professional Memberships
- International Society for ECT and Neurostimulation (ISEN)Executive Officer-Secretary
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: